Partners

The ASTERIX consortium is a collaboration with partners in the Netherlands, Germany, Austria, Spain and the UK. The consortium partners reflect a well-balanced cooperation involving universities, hospitals, patient organizations and industry statisticians across the EU.

The consortium as a whole unites expertise in innovative statistical methodology, clinical science for rare diseases, drug development, patient involvement, regulatory science and research ethics. This will ensure both synergy as well as critical mass in the execution of the ASTERIX project.